Supplementary Figure 2 from Selective Activity of the Histone Deacetylase Inhibitor AR-42 against Leukemia Stem Cells: A Novel Potential Strategy in Acute Myelogenous Leukemia
Year: 2023
Type: supplementary-materials
Abstract: PDF - 3889K, AR-42 demonstrates higher activity against a panel of leukemia cell lines in contrast to PTL
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W4362494021
